HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Riichiro Abe Selected Research

Eosinophilia

10/2017A case of non-episodic angioedema with eosinophilia induced by influenza vaccine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Riichiro Abe Research Topics

Disease

13Neoplasms (Cancer)
04/2022 - 02/2004
8Stevens-Johnson Syndrome (Lyell's Syndrome)
07/2020 - 05/2003
6Atopic Dermatitis (Atopic Eczema)
02/2024 - 07/2006
5Mycosis Fungoides
02/2022 - 05/2006
5Inflammation (Inflammations)
04/2011 - 04/2004
5Melanoma (Melanoma, Malignant)
01/2008 - 02/2004
4Skin Manifestations
09/2021 - 07/2009
4Hemangiosarcoma (Angiosarcoma)
10/2020 - 05/2013
4Bullous Pemphigoid (Pemphigoid)
02/2020 - 01/2008
4Diabetic Retinopathy (Retinopathy, Diabetic)
01/2008 - 12/2002
3Cicatrix (Scar)
04/2024 - 08/2022
3Drug-Related Side Effects and Adverse Reactions
04/2024 - 07/2014
3Junctional Epidermolysis Bullosa (Epidermolysis Bullosa Letalis)
01/2023 - 01/2009
3Psoriasis (Pustulosis Palmaris et Plantaris)
03/2021 - 09/2002
3Epidermolysis Bullosa
04/2017 - 08/2010
3Wounds and Injuries (Trauma)
02/2008 - 12/2005
2Necrosis
04/2024 - 12/2014
2Pruritus (Itching)
02/2024 - 09/2020
2Erythema
01/2024 - 07/2015
2Eosinophilic pustular folliculitis
10/2023 - 03/2013
2Ichthyosis (Xeroderma)
03/2023 - 10/2016
2Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara)
01/2023 - 01/2020
2Dystonia (Limb Dystonia)
01/2023 - 01/2020
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
04/2017 - 01/2003
2Pemphigus (Pemphigus Vulgaris)
01/2017 - 03/2012
2Eye Diseases (Eye Disease)
01/2008 - 04/2004
2Neoplasm Metastasis (Metastasis)
06/2007 - 02/2004
1Eczema
02/2024
1Conjunctivitis
12/2023
1Blepharitis
12/2023
1autosomal recessive Candidiasis familial chronic mucocutaneous
10/2023
1Trichophyton infection
10/2023
1Epidermolytic Hyperkeratosis (Bullous Congenital Ichthyosiform Erythroderma)
03/2023
1Fever (Fevers)
08/2022
1Sepsis (Septicemia)
08/2022
1Hypertriglyceridemia
02/2022
1Neutropenia
02/2022
1Hypercholesterolemia
02/2022
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
02/2022
1Chondrodysplasia Punctata (Stippled Epiphyses)
09/2021
1Diverticulitis
03/2021
1Embolism (Embolus)
01/2021
1Disease Progression
12/2020

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
10/2023 - 12/2002
9Macrophage Migration-Inhibitory FactorsIBA
04/2011 - 03/2002
6Biomarkers (Surrogate Marker)IBA
02/2024 - 08/2018
6Fas Ligand Protein (Fas Ligand)IBA
12/2008 - 01/2003
5Collagen Type XVIIIBA
04/2017 - 01/2009
5pigment epithelium-derived factorIBA
03/2010 - 04/2004
4CytokinesIBA
04/2024 - 07/2006
3AntigensIBA
04/2024 - 04/2017
3dupilumabIBA
12/2023 - 09/2020
3Immunoglobulins (Immunoglobulin)IBA
07/2020 - 08/2015
3EnzymesIBA
01/2018 - 05/2003
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2013 - 04/2004
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
04/2024 - 01/2018
2HLA Antigens (Human Leukocyte Antigens)IBA
04/2024 - 01/2018
2Adrenal Cortex Hormones (Corticosteroids)IBA
04/2024 - 02/2020
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
02/2024 - 09/2020
2Indomethacin (Indometacin)FDA LinkGeneric
10/2023 - 03/2013
2DystoninIBA
01/2023 - 01/2020
2SteroidsIBA
08/2022 - 08/2015
2AntibodiesIBA
10/2020 - 04/2017
2Immunoglobulin E (IgE)IBA
09/2020 - 07/2009
2LigandsIBA
09/2020 - 12/2006
2Infliximab (Remicade)FDA Link
10/2018 - 02/2018
2Peptides (Polypeptides)IBA
01/2018 - 03/2010
2ChemokinesIBA
04/2017 - 12/2006
2Immunoglobulin A (IgA)IBA
04/2017 - 03/2012
2Immunoglobulin G (IgG)IBA
04/2017 - 01/2017
2DNA (Deoxyribonucleic Acid)IBA
07/2009 - 12/2004
2Advanced Glycation End ProductsIBA
01/2008 - 02/2004
2Receptor for Advanced Glycation End ProductsIBA
06/2007 - 02/2004
2Neutralizing AntibodiesIBA
12/2006 - 02/2004
2GlyceraldehydeIBA
02/2004 - 12/2002
2glycolaldehydeIBA
02/2004 - 12/2002
1Janus KinasesIBA
04/2024
1Immunologic Factors (Immunomodulators)IBA
04/2024
1Sulfasalazine (Azulfidine)FDA LinkGeneric
04/2024
1Chemokine CCL26IBA
02/2024
1AntipyreticsIBA
01/2024
1Analgesics (Analgesic Drugs)IBA
01/2024
1Interleukin-18 (Interleukin 18)IBA
03/2023
1COVID-19 VaccinesIBA
01/2023
1S100 Proteins (S 100 Protein)IBA
04/2022
1Mucin-1 (CA 15-3 Antigen)IBA
04/2022
1Bexarotene (LGD1069)FDA Link
02/2022
1Carrier Proteins (Binding Protein)IBA
09/2021
1emopamil (levemopamil)IBA
09/2021
1risankizumabIBA
03/2021
1PolymersIBA
01/2021
1MicroRNAs (MicroRNA)IBA
12/2020
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
10/2020

Therapy/Procedure

14Therapeutics
08/2022 - 02/2004
3Bone Marrow Transplantation (Transplantation, Bone Marrow)
07/2015 - 08/2010
3Drug Therapy (Chemotherapy)
05/2013 - 06/2007
2Hematopoietic Stem Cell Transplantation
03/2016 - 06/2009
2Intradermal Injections
02/2008 - 12/2006
1Precision Medicine
02/2024
1Endovascular Procedures
01/2021